Amy Burroughs

Biotech executives call for action on reproductive health rights. timmermanreport.com/2022/10/biotec…

There’s a difference between mentoring and sponsoring. Are you sponsoring women and members of other underrepresented groups? An enlightening podcast - and only 5 min long. Hat tip @Angiejyou podcasts.apple.com/us/podcast/the…

Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/ nopatientleftbehind.docsend.com/view/a6bxibzxy…

Cleave's study showed "deep and really good evidence of synergy by activat­ing DNA damage and inhibiting VCP" drugdiscoverynews.com/killing-cancer…

We at Cleave Therapeutics are thrilled to partner with CASI Pharmaceuticals to develop CB-5339 in Greater China and support development globally of this novel agent for people with cancer.

Thanks to all of the collaborators and patients who have made our ongoing Phase 1 trial of CB-5339 in AML/MDS possible. Proud to have the details and new supporting data featured at ASH 2020.

Cleave Therapeutics treats first patient in acute myeloid leukemia/myelodisplastic syndrome Phase 1 trial with CB-5339 cleavetherapeutics.com/wp-content/upl…

@AskAmex Amex won't provide access to Centurion lounge for a parent with unaccompanied minors. Ridiculous.

Thrilled to be leading this team and announcing our plans at Cleave Therapeutics @CleaveTherapeu1 to get into the clinic in AML and solid tumors. Thanks to our great team, investors and the National Cancer Institute @theNCI #BeatAML #cancersucks #VCPDisease

@rtnarch I would call Marie Budev at Cleveland Clinic